|
Thursday, April 28, 2011
6pm - 8pm EST (registration: 5:30 - 6:00pm) Philadelphia Downtown Marriott, 1201 Market Street, Philadelphia, PA
| |
|
Sepsis is a leading killer in the U.S., striking more than 750,000 patients each year. Despite new therapies and guidelines developed over the past decade, Sepsis incidence and mortality remain high. This symposium will explore the challenges of Sepsis diagnosis and emerging patient care practices and protocols for addressing them. In particular, speakers will focus on Procalcitonin (PCT), increasingly recognized as the most promising marker for risk stratification to progression to Severe Sepsis or Septic Shock. The interactive session will feature actual patient case studies and will provide opportunities for audience questions and dialog with the speaker.
Intended Audience
This symposium is intended for physicians, doctors of pharmacy, and physician extenders, such as nurse
practitioners and nurses, who deal with patients with Sepsis. This includes those with practices in pulmonology,
critical care medicine, cardiothoracic surgery, pediatric pulmonology, neonatology, and pediatric critical care medicine.
Click here to register for this symposium. |
|